Follow
Michael Boyle
Michael Boyle
Johns Hopkins University School of Medicine
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Lumacaftor–ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR
CE Wainwright, JS Elborn, BW Ramsey, G Marigowda, X Huang, M Cipolli, ...
New England Journal of Medicine 373 (3), 220-231, 2015
14942015
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
HF Weisman, T Bartow, MK Leppo, HC Marsh Jr, GR Carson, MF Concino, ...
Science 249 (4965), 146-151, 1990
12411990
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation
FJ Accurso, SM Rowe, JP Clancy, MP Boyle, JM Dunitz, PR Durie, ...
New England Journal of Medicine 363 (21), 1991-2003, 2010
9072010
Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health
PA Flume, BP O'Sullivan, KA Robinson, CH Goss, PJ Mogayzel Jr, ...
American journal of respiratory and critical care medicine 176 (10), 957-969, 2007
7972007
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
JP Clancy, SM Rowe, FJ Accurso, ML Aitken, RS Amin, MA Ashlock, ...
Thorax 67 (1), 12-18, 2012
6482012
Guide to bone health and disease in cystic fibrosis
RM Aris, PA Merkel, LK Bachrach, DS Borowitz, MP Boyle, SL Elkin, ...
The Journal of Clinical Endocrinology & Metabolism 90 (3), 1888-1896, 2005
5522005
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
BC Tang, M Dawson, SK Lai, YY Wang, JS Suk, M Yang, P Zeitlin, ...
Proceedings of the National Academy of Sciences 106 (46), 19268-19273, 2009
5202009
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised …
MP Boyle, SC Bell, MW Konstan, SA McColley, SM Rowe, E Rietschel, ...
The lancet Respiratory medicine 2 (7), 527-538, 2014
5162014
Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis
EC Dasenbrook, W Checkley, CA Merlo, MW Konstan, N Lechtzin, ...
Jama 303 (23), 2386-2392, 2010
3882010
International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating …
AL Quittner, J Abbott, AM Georgiopoulos, L Goldbeck, B Smith, ...
Thorax 71 (1), 26-34, 2016
3632016
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles
JS Suk, SK Lai, YY Wang, LM Ensign, PL Zeitlin, MP Boyle, J Hanes
Biomaterials 30 (13), 2591-2597, 2009
3552009
Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis
EC Dasenbrook, CA Merlo, M Diener-West, N Lechtzin, MP Boyle
American journal of respiratory and critical care medicine 178 (8), 814-821, 2008
3442008
Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax
PA Flume, PJ Mogayzel Jr, KA Robinson, RL Rosenblatt, L Quittell, ...
American journal of respiratory and critical care medicine 182 (3), 298-306, 2010
3222010
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
MP Boyle, K De Boeck
The Lancet Respiratory Medicine 1 (2), 158-163, 2013
3112013
Longitudinal association between medication adherence and lung health in people with cystic fibrosis
MN Eakin, A Bilderback, MP Boyle, PJ Mogayzel, KA Riekert
Journal of Cystic Fibrosis 10 (4), 258-264, 2011
2722011
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation
CS Schneider, Q Xu, NJ Boylan, J Chisholm, BC Tang, BS Schuster, ...
Science advances 3 (4), e1601556, 2017
2622017
Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate
PL Zeitlin, M Diener-West, RC Rubenstein, MP Boyle, CKK Lee, ...
Molecular Therapy 6 (1), 119-126, 2002
2532002
The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis
KA Riekert, SJ Bartlett, MP Boyle, JA Krishnan, CS Rand
Chest 132 (1), 231-237, 2007
2462007
CFTR modulator theratyping: Current status, gaps and future directions
JP Clancy, CU Cotton, SH Donaldson, GM Solomon, DR VanDevanter, ...
Journal of Cystic Fibrosis 18 (1), 22-34, 2019
2412019
Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
JS Suk, AJ Kim, K Trehan, CS Schneider, L Cebotaru, OM Woodward, ...
Journal of controlled release 178, 8-17, 2014
2022014
The system can't perform the operation now. Try again later.
Articles 1–20